#United States #New York #Securities Fraud #Rosen Law Firm #3D Systems

3D Systems Shareholders: Seize Your Opportunity to Act

The Rosen Law Firm, a respected name in global investor rights, has issued an urgent reminder to purchasers of 3D Systems Corporation (NYSE: DDD) securities. If you bought shares between August 13, 2024, and May 12, 2025, you may have the chance to join a class action lawsuit aimed at addressing alleged securities fraud. Investors are encouraged to act before the crucial deadline on August 12, 2025, which signifies the last day to apply to be the lead plaintiff.

The Implications of the Lawsuit

If you are among those who acquired shares during the specified Class Period, you could be eligible for compensation without incurring any out-of-pocket expenses, thanks to a contingency fee arrangement offered by the Rosen Law Firm. Joining this class action can be a vital step in holding accountable those who misled investors and contributed to potential financial losses. The class action lawsuit alleges that significant false and misleading statements were made during the Class Period, which ultimately harmed the shareholders.

What You Need to Know

Participating in this class action means you would be represented as part of a larger group seeking justice. To join the lawsuit, investors should visit this link or contact Phillip Kim, Esq. through a toll-free call at 866-767-3653. It’s also important to note that until a class is certified, individual investors are not legally represented unless they engage legal counsel of their own choosing.

Why Choose Rosen Law Firm?

Potential plaintiffs often wonder which law firm to trust with their case. The Rosen Law Firm stands out due to its proven track record in securing successful outcomes for investors. They have achieved record-breaking settlements within securities class actions and are consistently ranked highly for their litigation success. In 2019 alone, the firm secured over $438 million for investors through various settlements and has gained recognition for their approach towards legal representation in high-stakes cases.

Background of the Allegations

The allegations surrounding 3D Systems focus on a few key issues. Defendants are accused of failing to adequately disclose the negative impacts that diminished customer spending had on the company while overstating its financial resilience. Furthermore, there are claims that new milestone criteria related to a partnership with United Therapeutics Corporation adversely influenced the revenue of 3D Systems' Regenerative Medicine Program. The lawsuit contends that due to these misrepresentations, the public statements made by 3D Systems during the relevant timeframe were fundamentally misleading and resulted in investor losses when the truth emerged.

Moving Forward

This class action presents a timely opportunity for affected shareholders to take action against the entities involved in the alleged fraud. Interested parties should ensure they act before the August 12 deadline to maintain their right to be considered as potential lead plaintiffs. Alternatively, individual investors may opt to engage counsel independently or remain absent at this moment without forfeiting their opportunity to receive compensation should the class action prove successful in the future.

Stay Updated

For ongoing updates and further information about the case, it’s advisable to follow the Rosen Law Firm on various social channels or their website. Investing the time to understand the legal landscape surrounding your investments could prove beneficial in the long run.

In conclusion, being proactive in joining this lawsuit against 3D Systems Corporation could be an essential path to reclaiming losses and demanding accountability from corporate mismanagement. For those who seek justice, the window of opportunity is closing fast, making immediate action necessary.

For anyone with questions or who needs assistance, don’t hesitate to reach out to the Rosen Law Firm, where team members are readily available to provide the necessary support and guidance.